about
Data on necrotic and apoptotic cell death in acute myocardial ischemia/reperfusion injury: the effects of CaMKII and angiotensin AT1 receptor inhibitionAnalysis of necroptotic proteins in failing human hearts.Anti-atherosclerotic molecules targeting oxidative stress and inflammation.Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.Hypercholesterolemia downregulates autophagy in the rat heart.Role of catecholamine oxidation in sudden cardiac death.The role of PPAR in myocardial response to ischemia in normal and diseased heart.Pleiotropic preconditioning-like cardioprotective effects of hypolipidemic drugs in acute ischemia-reperfusion in normal and hypertensive rats.Necroptotic cell death in failing heart: relevance and proposed mechanisms.Evidence of necroptosis in hearts subjected to various forms of ischemic insults.Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress.Erratum to: Hypercholesterolemia downregulates autophagy in the rat heart.Erratum to: Analysis of necroptotic proteins in failing human hearts.Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.Mitigation of postischemic cardiac contractile dysfunction by CaMKII inhibition: effects on programmed necrotic and apoptotic cell death.Modification of epinephrine-induced arrhythmias by N-acetyl-L-cysteine and vitamin E.The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo.Potential of sulphur-containing amino acids in the prevention of catecholamine-induced arrhythmias.Oxidative activation of CaMKIIδ in acute myocardial ischemia/reperfusion injury: A role of angiotensin AT1 receptor-NOX2 signaling axis.Noninvasive approach to mend the broken heart: Is "remote conditioning" a promising strategy for application in humans?Consecutive Isoproterenol and Adenosine Treatment Confers Marked Protection against Reperfusion Injury in Adult but Not in Immature Heart: A Role for Glycogen.Pleiotropic Effects of Simvastatin on Some Calcium Regulatory and Myofibrillar Proteins in Ischemic/Reperfused Heart: Causality of Statins Cardioprotection?Attenuation of Diabetes-induced Cardiac and Subcellular Defects by Sulphur-containing Amino Acids.Determination of Novel Highly Effective Necrostatin Nec-1s in Rat Plasma by High Performance Liquid Chromatography Hyphenated with Quadrupole-Time-of-Flight Mass SpectrometryPPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia–reperfusion injury: involvement of PI3K–AktCardioprotection of ischaemic preconditioning is associated with inhibition of translocation of MLKL within the plasma membrane.Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injuryUpregulation of CaMKIIδ during ischaemia-reperfusion is associated with reperfusion-induced arrhythmias and mechanical dysfunction of the rat heart: involvement of sarcolemmal Ca2+-cycling proteinsβ-1 adrenoceptors and AT1 receptors may not be involved in catecholamine-induced lethal arrhythmias 1Hyperlipidaemia and cardioprotection: Animal models for translational studiesActivation of β1-adrenoceptors may not be involved in arrhythmogenesis in ischemic heart diseaseDifferent signalling in infarcted and non-infarcted areas of rat failing hearts: A role of necroptosis and inflammationGuidelines for evaluating myocardial cell death
P50
Q31070865-F025E6E2-9F6A-479E-B5F3-9DD221F92788Q33617839-CDCE3F89-9E55-4292-8A47-96915D713FCDQ37597238-28A54124-9431-4CD1-9BDB-3424CF225DA9Q37600622-FD54C9C1-02B4-4255-9C86-F130A9B2F3DDQ37717563-77FD561E-7921-4E22-A91A-321841B631FBQ37768219-80C175AB-1A5A-469C-B220-1A5B4F5E8DD0Q37963320-941BDC29-634F-4483-8E8C-4E8ABFE4E19FQ38475188-FF36FE86-9A01-4FC8-8EBF-FD598242B7D1Q38731479-B69D80E2-CFE3-4620-8A6B-33D43815F6ACQ38803858-8B208D52-A96E-40BE-A9F8-DC9E37B8F22AQ41630655-11F74402-D6E2-4182-94A1-BCA960D00C9BQ42331845-05415750-86B9-45F3-9A8D-D9E077AF6C1BQ42352142-E89EF9C6-C565-4F90-B046-D9C064B877EAQ42472660-075814C8-997B-41BB-8D84-9BC45BBE7040Q43467323-60415A37-8D11-4920-95ED-B6868B803C4DQ46064875-91433153-FBE0-4410-8BCF-38F4665FFD63Q47272237-08E553A0-886E-46C5-A57B-5DEE72685404Q47874202-2FDBD3A8-2695-47EE-AA1D-5DA3ECF20E6EQ47890573-9916666B-1724-4773-A8BB-AF9CAB1D2A3AQ48729784-85155492-99AB-441F-B3A1-B8E39A618AB6Q50055492-6AE92B98-D570-403E-A98B-4EA072832AF6Q51570085-12F2367C-9D48-44AE-9990-924AD4C2111DQ53475968-ADDEB9A6-CB42-4B68-9463-1415E323A1A0Q58697275-39D38D4B-B24E-4B0F-896D-C1A14EDE2C7BQ62588454-EDFC64AE-3F2E-418A-A848-FD55FE27E114Q64986588-E9640047-8746-48BE-A61B-C8744DC8AEDDQ80089602-1F34844E-4413-4B69-9E22-DA357FBFB8D3Q84095934-80AF9CD6-69E4-41B8-9602-B1AE86E6DE05Q90582321-02218C40-0DE5-4F58-AE81-D8BB6FDD5312Q91457346-CEAAD756-25DD-4281-90FA-56704604A03BQ91757685-E4D6A859-B1FF-49B4-9A5F-2559CBE43B1DQ92062445-EB2527AF-D448-435B-8D8C-802995ED5657Q92656956-52C2E5D4-C807-4E3F-83F1-6A6BBEEB40A6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A Adameová
@en
A Adameová
@nl
type
label
A Adameová
@en
A Adameová
@nl
prefLabel
A Adameová
@en
A Adameová
@nl
P31
P496
0000-0002-9803-043X